Elizabeth Garrett-Mayer to Recurrence
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Recurrence.
Connection Strength
0.061
-
Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C18-ceramide as a novel biomarker for monitoring response. Clin Cancer Res. 2011 Sep 15; 17(18):6097-105.
Score: 0.019
-
Effect of DNA methylation on identification of aggressive prostate cancer. Urology. 2008 Dec; 72(6):1234-9.
Score: 0.015
-
Phase II study of imatinib mesylate in patients with prostate cancer with evidence of biochemical relapse after definitive radical retropubic prostatectomy or radiotherapy. Urology. 2007 Mar; 69(3):526-31.
Score: 0.014
-
Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions. Biol Blood Marrow Transplant. 2006 Apr; 12(4):414-21.
Score: 0.013